Page last updated: 2024-08-23

ursodeoxycholic acid and Fatty Liver

ursodeoxycholic acid has been researched along with Fatty Liver in 83 studies

Research

Studies (83)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (3.61)	18.2507
2000's	46 (55.42)	29.6817
2010's	32 (38.55)	24.3611
2020's	2 (2.41)	2.80

Authors

Authors	Studies
Azzalini, L; Lirussi, F; Orando, S; Orlando, R	2
Chen, T; Cheng, L; Guo, M; Li, B; Liu, J; Liu, P; Qiao, X; She, J; Wei, Y; Wu, Y; Xi, W; Yuan, Z; Zhou, J	1
Mehtiyev, SN; Mehtiyeva, OA	1
D'Aniello, R; Paolella, G; Pierri, L; Vajro, P	1
Chen, YP; Jin, X; Li, YM; Ma, KF; Xiang, Z; Yang, YD; Ye, YF; Zheng, L	1
Henry, L; Mehta, R; Mishra, A; Reyes, MJ; Younossi, ZM	1
Luzina, EV; Tomina, EA; Zhilina, AA	1
Avalueva, EB; Ivanov, SV; Lapinskiĭ, IV; Orishak, EA; Skazyvaeva, EV; Tkachenko, EI	1
Kanno, K; Kishikawa, N; Mizooka, M; Sugiyama, A; Tazuma, S; Yokobayashi, K	1
Abel, T; Fehér, J	1
Blum, HE; Panther, E	1
Harrison, SA; Kashi, MR; Torres, DM	1
Dhawan, A; Dziechciarz, P; Horvath, A; Socha, P; Szajewska, H; Vajro, P	1
Burhenne, J; Chamulitrat, W; Pathil, A; Rehlen, T; Stremmel, W	1
Ratziu, V; Zelber-Sagi, S	1
Enjoji, M; Kato, M; Kohjima, M; Kotoh, K; Machida, K; Matsunaga, K; Nakamuta, M; Nakashima, M	1
Arnold, JC; Berg, T; Cordes, HJ; Hein, J; Herrmann, G; Leuschner, UF; Lindenthal, B; Rössle, M; Zeuzem, S	1
Butikov, VP; Evsiukov, KB; Fomin, AA; Karshieva, AV; Kuchmin, AN; Rezvan, VV	1
Cho, YM; Jeon, J; Kang, GH; Kim, JT; Kim, S; Lee, HK; Park, HS; Park, KS; Yang, JS	1
Beraza, N; Bischoff, SC; Boekschoten, M; Ehedego, H; Mueller, M; Ofner-Ziegenfuss, L; Trauner, M; Trautwein, C	1
Dufour, JF; Haedrich, M	1
Bastard, JP; Bonnefont-Rousselot, D; de Ledinghen, V; Larrey, D; Mathurin, P; Maynard, M; Oberti, F; Ratziu, V; Renou, C; Rivière, M; Serfaty, L; Sogni, P; Spénard, J; Wartelle-Bladou, C	1
Álvarez Ferre, J; González Jiménez, E; Schmidt Río-Valle, J	1
Carvalho, RA; Jones, JG; Nunes, PM; Palmeira, CM; Rolo, AP	1
Fickert, P; Lackner, C; Marschall, HU; Thorell, A; Trauner, M; Wagner, M; Zollner, G	1
Dumortier, J; Guillaud, O; Hervieu, V; Pietu, F; Scoazec, JY; Vallin, M; Walter, T	1
Ishii, S; Ohta, T; Sakai, K; Shiraishi, M; Tsuchida, T	1
Chamulitrat, W; Mueller, J; Pathil, A; Stremmel, W; Warth, A	1
Harrison, SA; Paredes, AH; Torres, DM	1
Huang, C; Jin, Y; Li, J; Liu, LP; Lu, C; Lü, XW; Wang, JQ; Zhang, L; Zou, YH	1
Grigor'eva, IN	2
Li, L; Wang, JY; Wu, SD	1
Afonso, MB; Borralho, PM; Castro, RE; Cortez-Pinto, H; Ferreira, DM; Machado, MV; Rodrigues, CM	1
Oĭnotkinova, OSh	1
D'Aniello, R; De Micco, I; Lenta, S; Paolella, G; Parenti, G; Pignata, C; Salerno, M; Vajro, P	1
Ratziu, V	1
Dufour, JF; Liechti, F	1
Duggan, C; Raphael, BP	1
Agrawal, S; Bonkovsky, HL	1
Altekin, E; Astarcioglu, H; Astarcioglu, I; Gonen, O; Okan, A; Sagol, O; Tankurt, E	1
Lanzoni, VP; Parise, ER; Santos, VN; Shigueoka, D; Szejnfeld, J	1
Beergabel, M; Knobler, H; Malnick, SD	1
Iida, N; Koike, M; Ogawa, K; Oshimi, K; Sekigawa, I	1
Adim, SB; Dolar, E; Gulten, M; Gurel, S; Kiyici, M; Memik, F; Nak, SG; Savci, G; Yerci, O	1
Akimoto, T; Itoh, S; Kanazuka, A	1
Brancati, FL; Clark, JM	1
Angulo, P; Burgart, L; Colin, P; Harrison, ME; Heathcote, EJ; Jorgensen, R; Kowdley, KV; Lindor, KD; Lymp, JF	1
Bauditz, J; Dippe, P; Lochs, H; Pirlich, M; Schmidt, HH	1
Braegger, C	1
Harrison, SA; Neuschwander-Tetri, BA	1
Dufour, JF; Oneta, CM	1
Bugianesi, E; Marchesini, G; Marzocchi, R; Villanova, N	1
Mitsuyoshi, H; Nakashima, T; Okanoue, T; Sumida, Y	1
Durst, PR; Elitsur, Y; Lawrence, Z; Wang, R	1
Fan, JG; Li, MS; Tia, LY; Wang, GL; Xu, ZJ; Zhong, L	1
Akarca, US; Akay, S; Batur, Y; Ersöz, G; Günşar, F; Karasu, Z	1
Ahmed, MH	1
Comar, KM; Sterling, RK	1
Al-Osaimi, AM; Argo, CK; Caldwell, SH; Chang, CY	1
Galle, PR; Siebler, J	1
Kobayashi, K; Tanaka, N; Yazaki, M	1
Angulo, P; Lindor, K; Lymp, J; St Sauver, J; Suzuki, A	1
Timmer, A	1
Akimoto, T; Itoh, S; Kono, M	1
Georgescu, EF; Georgescu, M	1
Chabli, A; Colin, P; Elimadi, A; Haddad, PS; Ouazzani-Chahdi, A; Spénard, J	1
Il'chenko, LIu; Khomeriki, SG; Mel'nikova, NV; Ovsiannikova, ON; Zvenigorodskaia, LA	1
Allard, JP; Raman, M	1
Moseley, RH	1
Khomeriki, SG; Lazebnik, LB; Mel'nikova, NV; Ovsiannikova, ON; Samsonova, NG; Zvenigorodskaia, LA	1
Barshop, NJ; Lavine, JE; Schwimmer, JB; Sirlin, CB	1
Younossi, ZM	1
Abdelmalek, M; Lindor, KD; Ludwig, J	1
Crippin, JS; Gores, GJ; Gossard, A; Laurin, J; Lindor, KD; Ludwig, J; McGill, DB; Rakela, J	1
Egawa, I; Kinoshita, H; Kohno, S; Komatsu, K; Matsuo, I; Nakamura, T; Omagari, K; Shirono, K; Yamasaki, Y	1
Andrade, RJ; García-Escaño, MD	1
Sokol, RJ	1
Kumar, KS; Malet, PF	1
Blechacz, B; Herrmann, T; Mueller, S; Rost, D; Stremmel, W	1
Bischoff, A	1

Reviews

33 review(s) available for ursodeoxycholic acid and Fatty Liver

Article	Year
Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis. The Cochrane database of systematic reviews, 2020, 07-09, Volume: 7 Topics: Bile Acids and Salts; Cholagogues and Choleretics; Fatty Liver; Humans; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2020
[[New Paradigm Challenges of Steatosis Treatment in the Practice Therapist].] Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2016, Issue:5 Topics: Adult; Drug Combinations; Fatty Liver; Glycyrrhizic Acid; Humans; Liver Cirrhosis; Liver Function Tests; Male; Phosphatidylcholines; Practice Patterns, Physicians'; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid	2016
The role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review. BMC gastroenterology, 2013, Sep-23, Volume: 13 Topics: Cholagogues and Choleretics; Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Treatment Outcome; Ursodeoxycholic Acid	2013
Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets. Alimentary pharmacology & therapeutics, 2014, Volume: 39, Issue:1 Topics: Bariatric Surgery; Fatty Liver; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactones; Metabolic Syndrome; Metformin; Non-alcoholic Fatty Liver Disease; Orlistat; Precision Medicine; Thiazolidinediones; Ursodeoxycholic Acid; Vitamin E; Weight Loss	2014
[Obesity and diseases of digestive organs]. Klinicheskaia meditsina, 2013, Volume: 91, Issue:6 Topics: Body Mass Index; Cholagogues and Choleretics; Cholelithiasis; Diet Therapy; Endoscopy, Gastrointestinal; Fatty Liver; Gastroesophageal Reflux; Health Behavior; Humans; Life Style; Non-alcoholic Fatty Liver Disease; Obesity; Risk Factors; Ursodeoxycholic Acid	2013
AISF position paper on liver disease and pregnancy. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:2 Topics: Adrenal Cortex Hormones; Antihypertensive Agents; Budd-Chiari Syndrome; Calcium Channel Blockers; Cholagogues and Choleretics; Cholelithiasis; Cholestasis, Intrahepatic; Eclampsia; Fatty Liver; Female; Fluid Therapy; HELLP Syndrome; Hepatitis, Viral, Human; Humans; Hyperemesis Gravidarum; Italy; Liver Diseases; Magnesium Sulfate; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Societies, Medical; Thiamine; Ursodeoxycholic Acid; Viral Hepatitis Vaccines; Vitamin B Complex	2016
[Non-alcoholic fatty liver disease and cardiovascular risk]. Orvosi hetilap, 2008, Jul-13, Volume: 149, Issue:28 Topics: Antioxidants; Atherosclerosis; Carcinoma, Hepatocellular; Cardiovascular Diseases; Cytokines; Exercise; Fatty Acids, Nonesterified; Fatty Liver; Feeding Behavior; Humans; Insulin Resistance; Life Style; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Metabolic Syndrome; Obesity; Triglycerides; Ursodeoxycholic Acid	2008
[Liver diseases in pregnancy]. Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:44 Topics: Cholagogues and Choleretics; Cholestasis, Intrahepatic; Delivery, Obstetric; Fatty Liver; Female; HELLP Syndrome; Humans; Hyperemesis Gravidarum; Liver Diseases; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid	2008
Current and emerging therapies in nonalcoholic fatty liver disease. Seminars in liver disease, 2008, Volume: 28, Issue:4 Topics: Animals; Antioxidants; Bariatric Surgery; Body Mass Index; Cannabinoids; Cholagogues and Choleretics; Comorbidity; Fatty Liver; Glucagon-Like Peptide 1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Insulin Resistance; Lactones; Life Style; Metformin; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Thiazolidinediones; Treatment Outcome; Ursodeoxycholic Acid; Weight Loss	2008
Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review. Journal of pediatric gastroenterology and nutrition, 2009, Volume: 48, Issue:5 Topics: Acetylcysteine; Adult; Alanine Transaminase; Aspartate Aminotransferases; Carnitine; Child; Dietary Supplements; Drug Synergism; Drug Therapy, Combination; Fatty Liver; Humans; Hypoglycemic Agents; Liver; Metformin; Pioglitazone; Probucol; Randomized Controlled Trials as Topic; Thiazolidinediones; Ursodeoxycholic Acid; Vitamin E	2009
[Fatty liver and its clinical management in obese adolescents]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:1 Topics: Adiponectin; Adolescent; Apoptosis; Biomarkers; Chemokines; Disease Progression; Fatty Liver; Fibrosis; Hepatocytes; Humans; Hypertriglyceridemia; Insulin Resistance; Kupffer Cells; Liver Cirrhosis; Liver Transplantation; Metformin; Models, Biological; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Ursodeoxycholic Acid; Vitamin E	2011
Nonalcoholic fatty liver disease. Clinics in liver disease, 2012, Volume: 16, Issue:2 Topics: Antioxidants; Biomarkers; Cholagogues and Choleretics; Diabetes Complications; Fatty Acids, Omega-3; Fatty Liver; Female; Free Radical Scavengers; Humans; Hypoglycemic Agents; Life Style; Middle Aged; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Ursodeoxycholic Acid; Weight Loss	2012
[UDCA in the treatment of nonalcoholic fatty liver disease]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2011, Issue:11 Topics: Adiponectin; Apoptosis; Cholagogues and Choleretics; Fatty Liver; Hepatocytes; Humans; Insulin; Liver X Receptors; NAD; Non-alcoholic Fatty Liver Disease; Orphan Nuclear Receptors; Receptors, G-Protein-Coupled; Ursodeoxycholic Acid	2011
[UDCA in the treatment of nonalcoholic fatty liver disease]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2011, Issue:9 Topics: Cholagogues and Choleretics; Fatty Liver; Glucagon-Like Peptide 1; Humans; Non-alcoholic Fatty Liver Disease; Receptors, G-Protein-Coupled; Ursodeoxycholic Acid	2011
Ursodeoxycholic acid for nonalcoholic steatohepatitis. European journal of gastroenterology & hepatology, 2012, Volume: 24, Issue:11 Topics: Adult; Animals; Biomarkers; Biopsy; Chi-Square Distribution; Cholagogues and Choleretics; Fatty Liver; Humans; Liver; Non-alcoholic Fatty Liver Disease; Odds Ratio; Treatment Outcome; Ursodeoxycholic Acid	2012
Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions. Italian journal of pediatrics, 2012, Oct-17, Volume: 38 Topics: Antioxidants; Bariatric Surgery; Child; Cholagogues and Choleretics; Fatty Acids, Omega-3; Fatty Liver; Humans; Hypoglycemic Agents; Life Style; Obesity; Overweight; Prebiotics; Probiotics; Ursodeoxycholic Acid; Weight Loss	2012
Treatment of NASH with ursodeoxycholic acid: pro. Clinics and research in hepatology and gastroenterology, 2012, Volume: 36 Suppl 1 Topics: Anti-Inflammatory Agents; Cholagogues and Choleretics; Evidence-Based Medicine; Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid	2012
Non-alcoholic fatty liver: a common manifestation of a metabolic disorder. QJM : monthly journal of the Association of Physicians, 2003, Volume: 96, Issue:10 Topics: Algorithms; Antioxidants; Diabetes Mellitus, Type 2; Fatty Liver; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Liver Transplantation; Obesity; Prevalence; Risk Factors; Ursodeoxycholic Acid	2003
Pharmacologic management of nonalcoholic fatty liver disease. Clinics in liver disease, 2004, Volume: 8, Issue:3 Topics: Antihypertensive Agents; Antioxidants; Appetite Depressants; Fatty Liver; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Ursodeoxycholic Acid; Weight Loss	2004
[Alcoholic and non-alcoholic steatohepatitis]. Therapeutische Umschau. Revue therapeutique, 2004, Volume: 61, Issue:8 Topics: Alcoholism; Biopsy; Cholagogues and Choleretics; Diagnosis, Differential; Fatty Liver; Fatty Liver, Alcoholic; Gemfibrozil; Hepatitis; Hepatitis, Alcoholic; Humans; Hypolipidemic Agents; Insulin Resistance; Liver; Liver Transplantation; Middle Aged; Obesity; Pilot Projects; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones; Ultrasonography; Ursodeoxycholic Acid; Weight Loss	2004
Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. Best practice & research. Clinical gastroenterology, 2004, Volume: 18, Issue:6 Topics: Antioxidants; Cholagogues and Choleretics; Cytoprotection; Enzyme Inhibitors; Fatty Liver; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Lactones; Life Style; Lipase; Metformin; Orlistat; Phlebotomy; Thiazolidinediones; Ursodeoxycholic Acid	2004
[Treatment of nonalcoholic steatohepatitis (NASH)]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2004, Volume: 101, Issue:11 Topics: Cysteine; Diet; Drug Combinations; Fatty Liver; Glycine; Hepatitis; Humans; Insulin Resistance; Liver Transplantation; Obesity; Oleanolic Acid; Oxidative Stress; Ursodeoxycholic Acid; Vitamin E	2004
Review article: Drug therapy for non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics, 2006, Jan-15, Volume: 23, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Betaine; Cholagogues and Choleretics; Enzyme Inhibitors; Fatty Liver; Humans; Hypoglycemic Agents; Lipotropic Agents; Metformin; Pentoxifylline; Probucol; Thiazolidinediones; Ursodeoxycholic Acid; Vitamin E	2006
Therapy of NAFLD: antioxidants and cytoprotective agents. Journal of clinical gastroenterology, 2006, Volume: 40 Suppl 1 Topics: Acetylcysteine; Antioxidants; Betaine; Cholagogues and Choleretics; Disease Progression; Fatty Liver; Humans; Lipid Peroxidation; S-Adenosylmethionine; Ursodeoxycholic Acid; Vitamin E	2006
Treatment of nonalcoholic fatty liver disease. World journal of gastroenterology, 2006, Apr-14, Volume: 12, Issue:14 Topics: Alanine Transaminase; Animals; Antioxidants; Body Mass Index; Fatty Liver; Humans; Hypolipidemic Agents; Liver Transplantation; Metformin; Pioglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid; Weight Loss	2006
Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis. The Cochrane database of systematic reviews, 2007, Jan-24, Issue:1 Topics: Bile Acids and Salts; Cholagogues and Choleretics; Fatty Liver; Humans; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2007
[News from the Cochrane Library: treatment of nonalcoholic fatty liver disease and steatohepatitis]. Zeitschrift fur Gastroenterologie, 2007, Volume: 45, Issue:2 Topics: Antioxidants; Fatty Liver; Humans; Hypoglycemic Agents; Liver Function Tests; Probiotics; Randomized Controlled Trials as Topic; Survival Rate; Ursodeoxycholic Acid	2007
Parenteral nutrition related hepato-biliary disease in adults. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 2007, Volume: 32, Issue:4 Topics: Adult; Anti-Bacterial Agents; Biliary Tract Diseases; Cholestasis; Fatty Liver; Gallstones; Hepatitis; Humans; Intestines; Liver Diseases; Liver Transplantation; Parenteral Nutrition, Total; Ursodeoxycholic Acid	2007
Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics, 2008, Volume: 28, Issue:1 Topics: Adolescent; Adult; Antioxidants; Biomarkers; Child; Child, Preschool; Exercise Therapy; Fatty Liver; Female; Hepatocytes; Humans; Insulin Resistance; Male; Obesity; Oxidative Stress; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid; Weight Loss	2008
Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Alimentary pharmacology & therapeutics, 2008, Volume: 28, Issue:1 Topics: Antioxidants; Diabetes Mellitus, Type 2; Fatty Liver; Female; Humans; Hypolipidemic Agents; Insulin Resistance; Male; Obesity; Oxidative Stress; Risk Factors; Ursodeoxycholic Acid; Weight Loss	2008
[A case of primary biliary cirrhosis associated with fatty liver following delivery]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1997, Volume: 94, Issue:8 Topics: Adult; Cholagogues and Choleretics; Fatty Liver; Female; Humans; Liver Cirrhosis, Biliary; Puerperal Disorders; Ursodeoxycholic Acid	1997
Nonalcoholic steatohepatitis. Mayo Clinic proceedings, 2000, Volume: 75, Issue:7 Topics: Age Factors; Biopsy; Child; Cholagogues and Choleretics; Diabetes Complications; Disease Progression; Fatty Liver; Hepatitis; Humans; Hyperlipidemias; Hypertension, Portal; Liver Cirrhosis; Middle Aged; Obesity; Ursodeoxycholic Acid	2000
[Therapy of alcoholic and non-alcoholic fatty liver]. Der Internist, 2001, Volume: 42, Issue:12 Topics: Anti-Infective Agents; Antioxidants; Cholagogues and Choleretics; Clinical Trials as Topic; Diagnosis, Differential; Diet, Reducing; Exercise; Fatty Liver; Fatty Liver, Alcoholic; Hepatitis, Alcoholic; Humans; Hypolipidemic Agents; Lipotropic Agents; Liver Cirrhosis; Liver Function Tests; Risk Factors; Ursodeoxycholic Acid	2001

Trials

11 trial(s) available for ursodeoxycholic acid and Fatty Liver

Article	Year
High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial. Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:2 Topics: Adolescent; Adult; Aged; Double-Blind Method; Fatty Liver; Female; Humans; Male; Middle Aged; Ursodeoxycholic Acid; Young Adult	2010
[Condition of the intestinal tract microbiocenosis in patients with nonalcoholic fatty liver disease and the methods of its correction]. Voenno-meditsinskii zhurnal, 2010, Volume: 331, Issue:6 Topics: Cholagogues and Choleretics; Colon; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Fatty Liver; Feces; Female; Gastrointestinal Agents; Humans; Lactulose; Liver Function Tests; Male; Middle Aged; Ursodeoxycholic Acid	2010
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. Journal of hepatology, 2011, Volume: 54, Issue:5 Topics: Adult; Blood Glucose; Cholagogues and Choleretics; Dose-Response Relationship, Drug; Fatty Liver; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Treatment Outcome; Ursodeoxycholic Acid	2011
Ursodeoxycholic acid for treatment of fatty liver disease and dyslipidemia in morbidly obese patients. Digestive diseases (Basel, Switzerland), 2011, Volume: 29, Issue:1 Topics: Adult; Dyslipidemias; Fatty Liver; Female; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Obesity, Morbid; Ursodeoxycholic Acid	2011
Management of nonalcoholic steatohepatitis: an analytic review. Journal of clinical gastroenterology, 2002, Volume: 35, Issue:3 Topics: Diabetes Mellitus; Fatty Liver; Hepatitis; Humans; Hyperinsulinism; Iron; Leptin; Liver Transplantation; Risk Factors; Silymarin; Triglycerides; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid; Vitamin E	2002
A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2003, Volume: 36, Issue:6 Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Cholagogues and Choleretics; Double-Blind Method; Fatty Liver; Female; gamma-Glutamyltransferase; Humans; Liver Function Tests; Male; Obesity; Treatment Outcome; Ursodeoxycholic Acid	2003
Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2003, Volume: 17, Issue:12 Topics: Adult; Anticholesteremic Agents; Atorvastatin; Fatty Liver; Female; Hepatitis; Heptanoic Acids; Humans; Male; Middle Aged; Prospective Studies; Pyrroles; Ursodeoxycholic Acid	2003
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology (Baltimore, Md.), 2004, Volume: 39, Issue:3 Topics: Alanine Transaminase; Aspartate Aminotransferases; Cholagogues and Choleretics; Disease Progression; Double-Blind Method; Fatty Liver; Fibrosis; Humans; Liver; Necrosis; Ursodeoxycholic Acid	2004
Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2005, Volume: 16, Issue:3 Topics: Administration, Oral; Adult; Alanine Transaminase; Alkaline Phosphatase; Antioxidants; Ascorbic Acid; Aspartate Aminotransferases; Biomarkers; Cholagogues and Choleretics; Drug Therapy, Combination; Fatty Liver; Female; gamma-Glutamyltransferase; Humans; Male; Middle Aged; Oxidative Stress; Prospective Studies; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid; Vitamin E	2005
Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study. Journal of gastrointestinal and liver diseases : JGLD, 2007, Volume: 16, Issue:1 Topics: Adult; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Cholagogues and Choleretics; Fatty Liver; Female; Hematologic Agents; Hepatitis; Heptanoic Acids; Humans; Losartan; Male; Middle Aged; Pentoxifylline; Pyrroles; Treatment Outcome; Ursodeoxycholic Acid	2007
[Atherogenic dyslipidemia, non-alcohol steatohepatitis, methods of treatment]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2007, Issue:1 Topics: Adult; Aged; Biomarkers; Diet, Atherogenic; Dyslipidemias; Fatty Liver; Female; Humans; Lipids; Liver; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid	2007

Other Studies

39 other study(ies) available for ursodeoxycholic acid and Fatty Liver

Article	Year
Glycoursodeoxycholic acid ameliorates diet-induced metabolic disorders with inhibiting endoplasmic reticulum stress. Clinical science (London, England : 1979), 2021, 07-30, Volume: 135, Issue:14 Topics: Animals; Diet, High-Fat; Endoplasmic Reticulum Stress; Fatty Liver; Female; Humans; Lipid Metabolism; Liver; Male; Metabolic Diseases; Middle Aged; Obesity; Ursodeoxycholic Acid	2021
Treatment of NASH with ursodeoxycholic acid: pros and cons. More information in children. Clinics and research in hepatology and gastroenterology, 2013, Volume: 37, Issue:3 Topics: Anti-Inflammatory Agents; Cholagogues and Choleretics; Fatty Liver; Humans; Ursodeoxycholic Acid	2013
[Efficiency of ursodeoxycholic acid therapy in non-alcoholic fatty liver disease associated with metabolic syndrome]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2013, Issue:11 Topics: Adult; Cholagogues and Choleretics; Fatty Liver; Female; Humans; Intestinal Mucosa; Intestines; Male; Metabolic Syndrome; Middle Aged; Non-alcoholic Fatty Liver Disease; Russia; Time Factors; Ursodeoxycholic Acid	2013
Long-term administration of a Niemann-Pick C1-like 1 inhibitor, ezetimibe, does not worsen bile lithogenicity in dyslipidemic patients with hepatobiliary diseases. Journal of hepato-biliary-pancreatic sciences, 2016, Volume: 23, Issue:2 Topics: Anticholesteremic Agents; Bile; Cholesterol; Dyslipidemias; Ezetimibe; Fatty Liver; Female; Gallstones; Humans; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Phytosterols; Ursodeoxycholic Acid	2016
Bile salt-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide as a hepatoprotective agent. Hepatology (Baltimore, Md.), 2009, Volume: 50, Issue:1 Topics: Animals; Bile Acids and Salts; Cells, Cultured; Fatty Liver; Hepatitis; Lysophospholipids; Mice; Phospholipids; Ursodeoxycholic Acid	2009
Pharmacologic therapy of non-alcoholic steatohepatitis. Clinics in liver disease, 2009, Volume: 13, Issue:4 Topics: Angiotensin II Type 1 Receptor Blockers; Anti-Obesity Agents; Antioxidants; Betaine; Cholagogues and Choleretics; Clinical Trials as Topic; Fatty Liver; Free Radical Scavengers; Humans; Lactones; Lipotropic Agents; Orlistat; Pentoxifylline; Probucol; Thiazolidinediones; Tocopherols; Ursodeoxycholic Acid	2009
NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease. Lipids in health and disease, 2010, Mar-12, Volume: 9 Topics: Adipokines; Adult; Anticholesteremic Agents; Azetidines; Carbohydrates; Cholesterol; Ezetimibe; Fatty Liver; Female; Humans; Liver; Male; Membrane Proteins; Membrane Transport Proteins; Middle Aged; Obesity; Ursodeoxycholic Acid	2010
Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob mice. PloS one, 2010, Nov-05, Volume: 5, Issue:11 Topics: Administration, Oral; Amino Acids; Animals; Blotting, Western; Carbohydrate Metabolism; Cluster Analysis; Endoplasmic Reticulum; Fatty Liver; Gene Expression Profiling; Gene Expression Regulation; Glucose; Homeostasis; Lipid Peroxidation; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Taurine; Ursodeoxycholic Acid	2010
Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis. Gut, 2011, Volume: 60, Issue:3 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Proliferation; Diet, Fat-Restricted; Disease Progression; Down-Regulation; Drug Evaluation, Preclinical; Fatty Liver; Hepatocytes; Intracellular Signaling Peptides and Proteins; Lipids; Liver; Liver Cirrhosis; Mice; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Ursodeoxycholic Acid	2011
UDCA for NASH: end of the story? Journal of hepatology, 2011, Volume: 54, Issue:5 Topics: Cholagogues and Choleretics; Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2011
Ursodeoxycholic acid treatment of hepatic steatosis: a (13)C NMR metabolic study. NMR in biomedicine, 2011, Volume: 24, Issue:9 Topics: Acetyl Coenzyme A; Animals; Body Weight; Carbon Isotopes; Fatty Liver; Glucose; In Vitro Techniques; Liver; Magnetic Resonance Spectroscopy; Male; Organ Size; Oxidation-Reduction; Perfusion; Rats; Rats, Wistar; Tissue Extracts; Ursodeoxycholic Acid	2011
Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: long-term results. Clinics and research in hepatology and gastroenterology, 2012, Volume: 36, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Fatty Liver; Humans; Middle Aged; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Time Factors; Treatment Outcome; Ursodeoxycholic Acid; Vitamin E; Vitamins; Young Adult	2012
Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice. Metabolism: clinical and experimental, 2012, Volume: 61, Issue:7 Topics: Animals; Cholagogues and Choleretics; Cholesterol; Diabetes Mellitus, Type 2; Diet, High-Fat; Endoplasmic Reticulum Stress; Fatty Acids; Fatty Liver; Gene Expression Profiling; Hyperglycemia; Hyperinsulinism; Insulin Resistance; Lipid Metabolism; Male; Mice; Phosphorylation; Up-Regulation; Ursodeoxycholic Acid	2012
Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.), 2012, Volume: 55, Issue:5 Topics: Animals; Biopsy, Needle; Caspase 8; Diet; Disease Models, Animal; Down-Regulation; Fatty Liver; Hepatitis; Immunohistochemistry; Lipid Peroxidation; Lipogenesis; Liver Function Tests; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Random Allocation; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity; Transaminases; Triglycerides; Ursodeoxycholic Acid	2012
Protective effects of tiopronin against high fat diet-induced non-alcoholic steatohepatitis in rats. Acta pharmacologica Sinica, 2012, Volume: 33, Issue:6 Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Cholesterol; Cytochrome P-450 CYP2E1; Diet, High-Fat; Fatty Acids, Nonesterified; Fatty Liver; Lipid Peroxidation; Liver; Male; Rats; Rats, Sprague-Dawley; Tiopronin; Triglycerides; Ursodeoxycholic Acid	2012
miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. Journal of hepatology, 2013, Volume: 58, Issue:1 Topics: Animals; Apoptosis; Biopsy; Fatty Liver; Hepatocytes; Humans; Liver; Male; MicroRNAs; Non-alcoholic Fatty Liver Disease; Obesity, Morbid; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Signal Transduction; Sirtuin 1; Transcription, Genetic; Tumor Suppressor Protein p53; Ursodeoxycholic Acid	2013
[Specific features of hypolipidemic therapy in patients with abdominal ischemic disease]. Terapevticheskii arkhiv, 2012, Volume: 84, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Aorta, Abdominal; Atherosclerosis; Atorvastatin; Cholagogues and Choleretics; Drug Therapy, Combination; Fatty Liver; Female; Heptanoic Acids; Humans; Ischemia; Male; Middle Aged; Pyrroles; Ursodeoxycholic Acid; Young Adult	2012
Treatment of NASH with ursodeoxycholic acid: cons. Clinics and research in hepatology and gastroenterology, 2012, Volume: 36 Suppl 1 Topics: Anti-Inflammatory Agents; Cholagogues and Choleretics; Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Ursodeoxycholic Acid	2012
Prevention and treatment of intestinal failure-associated liver disease in children. Seminars in liver disease, 2012, Volume: 32, Issue:4 Topics: Cholagogues and Choleretics; Cholestasis; Fat Emulsions, Intravenous; Fatty Liver; Humans; Intestinal Diseases; Liver Cirrhosis; Liver Diseases; Parenteral Nutrition; Ursodeoxycholic Acid	2012
Effect of ursodeoxycholic acid on hepatic steatosis in rats. Digestive diseases and sciences, 2002, Volume: 47, Issue:11 Topics: Animals; Cholagogues and Choleretics; Fatty Liver; Male; Random Allocation; Rats; Rats, Wistar; Ursodeoxycholic Acid	2002
Ursodeoxycholic acid treatment of idiopathic thrombocytopenic purpura with liver dysfunction. European journal of haematology, 2003, Volume: 71, Issue:5 Topics: Adult; Fatty Liver; Female; Humans; Liver Diseases; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Ursodeoxycholic Acid	2003
Combined treatment with ursodeoxycholic acid and pioglitazone in a patient with NASH associated with type 2 diabetes and psoriasis. Digestive diseases and sciences, 2003, Volume: 48, Issue:11 Topics: Aged; Cholagogues and Choleretics; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fatty Liver; Hepatitis; Humans; Hypoglycemic Agents; Male; Pioglitazone; Psoriasis; Thiazolidinediones; Ursodeoxycholic Acid	2003
Negative trials in nonalcoholic steatohepatitis: why they happen and what they teach us. Hepatology (Baltimore, Md.), 2004, Volume: 39, Issue:3 Topics: Cholagogues and Choleretics; Clinical Trials as Topic; Fatty Liver; Humans; Research Design; Treatment Outcome; Ursodeoxycholic Acid	2004
Non-alcohol induced steatohepatitis in non-obese patients: treatment with ursodeoxycholic acid. The American journal of gastroenterology, 2004, Volume: 99, Issue:5 Topics: Adult; Aged; Body Mass Index; Body Weight; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatty Liver; Female; Humans; Liver Function Tests; Male; Middle Aged; Probability; Prognosis; Prospective Studies; Risk Assessment; Sampling Studies; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid	2004
NASH remains without a treatment ... URSO they say. Journal of pediatric gastroenterology and nutrition, 2004, Volume: 39, Issue:3 Topics: Child; Cholagogues and Choleretics; Fatty Liver; Humans; Pilot Projects; Safety; Treatment Outcome; Ursodeoxycholic Acid; Weight Loss	2004
Treatment for NASH: the value of histology. The American journal of gastroenterology, 2005, Volume: 100, Issue:1 Topics: Antioxidants; Cholagogues and Choleretics; Fatty Liver; Hepatitis; Humans; Transaminases; Treatment Outcome; Ursodeoxycholic Acid; Vitamin E	2005
Effects of ursodeoxycholic acid and/or low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia. World journal of gastroenterology, 2005, Apr-21, Volume: 11, Issue:15 Topics: Animals; Caloric Restriction; Cholagogues and Choleretics; Dietary Fats; Fatty Liver; Hyperlipidemias; Lipids; Liver; Male; Obesity; Rats; Rats, Sprague-Dawley; Ursodeoxycholic Acid	2005
Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): The other face of the coin of histology. Medical hypotheses, 2006, Volume: 66, Issue:3 Topics: Ascorbic Acid; Biopsy; Fatty Liver; Hepatitis; Humans; Liver; Transaminases; Ursodeoxycholic Acid; Vitamin E	2006
A lean man with nonalcoholic fatty liver disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2007, Volume: 5, Issue:3 Topics: Adult; Biopsy, Needle; Blood Chemical Analysis; Body Mass Index; Disease Progression; Fatty Liver; Follow-Up Studies; Humans; Immunohistochemistry; Liver Failure, Acute; Liver Function Tests; Liver Transplantation; Male; Thinness; Treatment Outcome; Ursodeoxycholic Acid	2007
Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis. Liver international : official journal of the International Association for the Study of the Liver, 2006, Volume: 26, Issue:10 Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Cohort Studies; Fatty Liver; Female; Humans; Liver; Longitudinal Studies; Male; Middle Aged; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2006
Psoriasis treated with ursodeoxycholic acid: three case reports. Clinical and experimental dermatology, 2007, Volume: 32, Issue:4 Topics: Aged; Biopsy; Cholagogues and Choleretics; Fatty Liver; Female; Humans; Middle Aged; Psoriasis; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid	2007
Combining ursodeoxycholic acid or its NO-releasing derivative NCX-1000 with lipophilic antioxidants better protects mouse hepatocytes against amiodarone toxicity. Canadian journal of physiology and pharmacology, 2007, Volume: 85, Issue:2 Topics: Amiodarone; Animals; Antioxidants; Ascorbic Acid; Butylated Hydroxytoluene; Cells, Cultured; Dose-Response Relationship, Drug; Fatty Liver; Hepatocytes; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Nitrates; Protective Agents; Superoxides; Ursodeoxycholic Acid	2007
Therapy for nonalcoholic fatty liver disease. Journal of clinical gastroenterology, 2008, Volume: 42, Issue:4 Topics: Animals; Antioxidants; Cholagogues and Choleretics; Disease Models, Animal; Fatty Liver; Glycine; Humans; Hypolipidemic Agents; Insulin Resistance; Liver; Mice; Oxazoles; Peroxisome Proliferator-Activated Receptors; Rats; Thiazolidinediones; Treatment Outcome; Ursodeoxycholic Acid; Vitamin E	2008
[Cholesterosis of the gall bladder and atherogenic dyslipidemia: etiology, pathogenesis, clinical symptoms, diagnosis and treatment]. Terapevticheskii arkhiv, 2008, Volume: 80, Issue:1 Topics: Adult; Aged; Biopsy; Cholagogues and Choleretics; Cholecystectomy, Laparoscopic; Cholesterol; Diagnosis, Differential; Dyslipidemias; Fatty Liver; Female; Follow-Up Studies; Gallbladder; Gallbladder Diseases; Humans; Male; Middle Aged; Prognosis; Ultrasonography; Ursodeoxycholic Acid	2008
Two cases from the spectrum of nonalcoholic steatohepatitis. Journal of clinical gastroenterology, 1995, Volume: 20, Issue:2 Topics: Adult; Aged; Biopsy; Fatty Liver; Female; Hepatitis; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Obesity; Ursodeoxycholic Acid	1995
Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology (Baltimore, Md.), 1996, Volume: 23, Issue:6 Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Clofibrate; Drug Evaluation; Fatty Liver; Female; gamma-Glutamyltransferase; Gastrointestinal Agents; Hepatitis; Humans; Hypolipidemic Agents; Male; Middle Aged; Pilot Projects; Ursodeoxycholic Acid	1996
[Fatty liver]. Medicina clinica, 2000, Apr-22, Volume: 114, Issue:15 Topics: Adult; Antioxidants; Cholagogues and Choleretics; Cross-Sectional Studies; Diabetes Complications; Fatty Liver; Fatty Liver, Alcoholic; Humans; Logistic Models; Male; Middle Aged; Obesity; Pilot Projects; Prognosis; Risk Factors; Spain; Ultrasonography; Ursodeoxycholic Acid; Vitamin E	2000
The chronic disease of childhood obesity: the sleeping giant has awakened. The Journal of pediatrics, 2000, Volume: 136, Issue:6 Topics: Alanine Transaminase; Aspartate Aminotransferases; Child; Chronic Disease; Fatty Liver; Health Promotion; Humans; Life Style; Liver Diseases; Obesity; Ursodeoxycholic Acid	2000
[Fatty liver and raised gamma-GT: it can happen to abstainers, too]. MMW Fortschritte der Medizin, 2002, Feb-14, Volume: 144, Issue:7 Topics: Cholagogues and Choleretics; Clinical Enzyme Tests; Diabetes Complications; Diagnosis, Differential; Fatty Liver; Female; gamma-Glutamyltransferase; Humans; Hypoglycemic Agents; Male; Metformin; Obesity; Risk Factors; Ursodeoxycholic Acid; Vitamin E	2002